Afferent Steps Boldly Into Neurotherapeutic Arena With New Shoe Insole
This article was originally published in The Gray Sheet
Executive Summary
Afferent expects to launch a non-invasive shoe insole technology for the palliative treatment of diabetic foot neuropathy in the second half of 2006